{
  "company_number": "08497840",
  "name": "Arcadia Pharma Limited",
  "url": "/company/08497840",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2013-04-22",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "21200",
      "description": "Manufacture of pharmaceutical preparations",
      "section": "C",
      "section_name": "Manufacturing",
      "url": "/sic/21200"
    }
  ],
  "registered_address": {
    "id": 2099674,
    "url": "/address/2099674",
    "line1": "UNIT 3 FELINFACH",
    "line2": "FFORESTFACH",
    "post_town": "SWANSEA",
    "county": "",
    "country": "",
    "postcode": "SA5 4HP"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08497840",
  "previous_names": [
    {
      "name": "Veradis Pharma Limited",
      "ceased_on": "2013-09-26"
    }
  ],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-09-30",
    "last_made_up": "2024-12-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/08497840/accounts/2024-12-31",
        "made_up_date": "2024-12-31",
        "period_start": "2024-12-31",
        "period_end": "2024-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "30.00",
        "tangible_fixed_assets": "252684.00",
        "debtors": "1436355.00",
        "cash_bank_in_hand": "294501.00",
        "current_assets": "2647094.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1337452.00",
        "total_assets_less_current_liabilities": "1590136.00",
        "net_assets_liabilities": "1199601.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/08497840/accounts/2023-12-31",
        "made_up_date": "2023-12-31",
        "period_start": "2023-12-31",
        "period_end": "2023-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "29.00",
        "tangible_fixed_assets": "100579.00",
        "debtors": "1010346.00",
        "cash_bank_in_hand": "505124.00",
        "current_assets": "2335428.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "990072.00",
        "total_assets_less_current_liabilities": "1090651.00",
        "net_assets_liabilities": "891853.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/08497840/accounts/2022-12-31",
        "made_up_date": "2022-12-31",
        "period_start": "2022-12-31",
        "period_end": "2022-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "29.00",
        "tangible_fixed_assets": "71962.00",
        "debtors": "982735.00",
        "cash_bank_in_hand": "32561.00",
        "current_assets": "1828302.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "704509.00",
        "total_assets_less_current_liabilities": "776471.00",
        "net_assets_liabilities": "480596.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2023.zip"
      },
      {
        "url": "/company/08497840/accounts/2021-12-31",
        "made_up_date": "2021-12-31",
        "period_start": "2021-12-31",
        "period_end": "2021-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "24.00",
        "tangible_fixed_assets": "86306.00",
        "debtors": "863428.00",
        "cash_bank_in_hand": "211748.00",
        "current_assets": "1618257.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "544947.00",
        "total_assets_less_current_liabilities": "631253.00",
        "net_assets_liabilities": "370150.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2022.zip"
      },
      {
        "url": "/company/08497840/accounts/2020-12-31",
        "made_up_date": "2020-12-31",
        "period_start": "2020-12-31",
        "period_end": "2020-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "20.00",
        "tangible_fixed_assets": "94120.00",
        "debtors": "774406.00",
        "cash_bank_in_hand": "119401.00",
        "current_assets": "1136174.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "321093.00",
        "total_assets_less_current_liabilities": "415213.00",
        "net_assets_liabilities": "144262.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2021.zip"
      },
      {
        "url": "/company/08497840/accounts/2019-12-31",
        "made_up_date": "2019-12-31",
        "period_start": "2019-12-31",
        "period_end": "2019-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "20.00",
        "tangible_fixed_assets": "132573.00",
        "debtors": "697000.00",
        "cash_bank_in_hand": "77137.00",
        "current_assets": "898419.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "142799.00",
        "total_assets_less_current_liabilities": "275372.00",
        "net_assets_liabilities": "-44388.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2020.zip"
      },
      {
        "url": "/company/08497840/accounts/2018-12-31",
        "made_up_date": "2018-12-31",
        "period_start": "2018-12-31",
        "period_end": "2018-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "22.00",
        "tangible_fixed_assets": "158932.00",
        "debtors": "534674.00",
        "cash_bank_in_hand": "63960.00",
        "current_assets": "612100.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "72272.00",
        "total_assets_less_current_liabilities": "231204.00",
        "net_assets_liabilities": "-67773.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2019.zip"
      },
      {
        "url": "/company/08497840/accounts/2017-12-31",
        "made_up_date": "2017-12-31",
        "period_start": "2017-12-31",
        "period_end": "2017-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "19.00",
        "tangible_fixed_assets": "137373.00",
        "debtors": "674037.00",
        "cash_bank_in_hand": "109572.00",
        "current_assets": "838336.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "372184.00",
        "total_assets_less_current_liabilities": "509557.00",
        "net_assets_liabilities": "219828.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2018.zip"
      },
      {
        "url": "/company/08497840/accounts/2016-12-31",
        "made_up_date": "2016-12-31",
        "period_start": "2016-12-31",
        "period_end": "2016-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": "24.00",
        "tangible_fixed_assets": "156923.00",
        "debtors": "320054.00",
        "cash_bank_in_hand": "97636.00",
        "current_assets": "520509.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "292274.00",
        "total_assets_less_current_liabilities": "449197.00",
        "net_assets_liabilities": "83670.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "99.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2017.zip"
      },
      {
        "url": "/company/08497840/accounts/2015-12-31",
        "made_up_date": "2015-12-31",
        "period_start": "2015-12-31",
        "period_end": "2015-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "119899.00",
        "debtors": "209914.00",
        "cash_bank_in_hand": "16079.00",
        "current_assets": "263156.00",
        "creditors_due_within_one_year": "205368.00",
        "creditors_due_after_one_year": "349289.00",
        "net_current_assets_liabilities": "87686.00",
        "total_assets_less_current_liabilities": "207585.00",
        "net_assets_liabilities": "-161244.00",
        "called_up_share_capital": "99.00",
        "profit_loss_account_reserve": "-161343.00",
        "shareholder_funds": "-161244.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2016.zip"
      },
      {
        "url": "/company/08497840/accounts/2014-12-31",
        "made_up_date": "2014-12-31",
        "period_start": "2014-12-31",
        "period_end": "2014-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "134238.00",
        "debtors": "78934.00",
        "cash_bank_in_hand": "14515.00",
        "current_assets": "128847.00",
        "creditors_due_within_one_year": "135515.00",
        "creditors_due_after_one_year": "350883.00",
        "net_current_assets_liabilities": "5332.00",
        "total_assets_less_current_liabilities": "139669.00",
        "net_assets_liabilities": "-211214.00",
        "called_up_share_capital": "99.00",
        "profit_loss_account_reserve": "-211313.00",
        "shareholder_funds": "-211214.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2015.zip"
      },
      {
        "url": "/company/08497840/accounts/2013-12-31",
        "made_up_date": "2013-12-31",
        "period_start": "2013-12-31",
        "period_end": "2013-12-31",
        "entity_name": "Arcadia Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "103600.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "50816.00",
        "creditors_due_within_one_year": "5690.00",
        "creditors_due_after_one_year": "210115.00",
        "net_current_assets_liabilities": "52126.00",
        "total_assets_less_current_liabilities": "155825.00",
        "net_assets_liabilities": "-54290.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "-54290.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2015.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08497840/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-05-06",
    "last_made_up": "2026-04-22"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mr Michael John Overy",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3347263",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent"
      ],
      "notified_on": "2017-04-01",
      "ceased_on": null,
      "nationality": "English",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Mr Jeffrey Raymond Albert Everett",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/2255499",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent"
      ],
      "notified_on": "2017-04-01",
      "ceased_on": null,
      "nationality": "Welsh",
      "country_of_residence": "Wales",
      "source": "snapshot"
    },
    {
      "name": "Mr Christopher John Colebrook",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/915610",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent"
      ],
      "notified_on": "2017-04-01",
      "ceased_on": null,
      "nationality": "Welsh",
      "country_of_residence": "Wales",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T05:12:20.351914+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}